The Georgetown Database of Cancer (G-DOC®) is designed to serve as a cutting-edge data integration platform and integrative knowledge discovery system for the oncology and translational research communities. By aggregating public and proprietary clinical and -omics data from across the Medical Center, G-DOC® is expected to help bring about significant advances in personalized medicine for patients and to promote identification of new drug targets and therapeutic modalities.
In 2014 we expanded G-DOC® into other clinical areas of interest including data from the 1000 genomes project, muscular dystrophy, and dementia. The enhanced platform, G-DOC® Plus, takes advantage of cloud computing to handle next generation sequencing (NGS) data so that they can be analyzed in the full context of other omics and clinical information.
To learn more about the specific capabilities of G-DOC® Plus, visit the G-DOC® Plus web portal.